AHIMA Responds to Information Blocking Rule

Wylecia Wiggs Harris, AHIMA CEO, PhD, CAE, says, “We look forward to reviewing the final rule in greater detail. We support the intent of the Cures Act to eradicate practices that unreasonably limit the access, exchange, and use of electronic health information for authorized and permitted purposes including patient access to their health information. However, given that the rule introduces a number of new definitions and terminologies and the significant economic impact of this rule, we are disappointed the Office of the National Coordinator for Health Information Technology did not heed stakeholders’ calls to issue an interim final rule.” 

— Source: AHIMA